Two Sigma Advisers’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-379,300
| Closed | -$436K | – | 2975 |
|
|
2022
Q1 | $436K | Buy |
379,300
+63,900
| +20% | +$73.5K | ﹤0.01% | 2052 |
|
|
2021
Q4 | $789K | Buy |
+315,400
| New | +$789K | ﹤0.01% | 1688 |
|
|
2021
Q2 | – | Sell |
-20,800
| Closed | -$181K | – | 2785 |
|
|
2021
Q1 | $181K | Buy |
20,800
+1,400
| +7% | +$12.2K | ﹤0.01% | 2370 |
|
|
2020
Q4 | $211K | Sell |
19,400
-152,800
| -89% | -$1.66M | ﹤0.01% | 2153 |
|
|
2020
Q3 | $2.05M | Buy |
172,200
+99,100
| +136% | +$1.18M | 0.01% | 1151 |
|
|
2020
Q2 | $1.17M | Buy |
+73,100
| New | +$1.17M | ﹤0.01% | 1501 |
|
|
2019
Q1 | – | Sell |
-12,400
| Closed | -$76K | – | 2490 |
|
|
2018
Q4 | $76K | Buy |
+12,400
| New | +$76K | ﹤0.01% | 2244 |
|